DK1250146T3
(en )
2004-04-26
Use of botulinum toxin in the treatment of diabetes
DK2412368T3
(en )
2013-11-04
Composition for the treatment of scars
DK1604681T3
(en )
2010-11-29
Use of botulinum toxin in the treatment of joint pain
DK1514556T3
(en )
2011-10-24
Pharmaceutical compositions with botulinum toxin
DK1259512T3
(en )
2003-12-29
Pteridine compounds for the treatment of psoreasis
IS5836A
(en )
2001-01-31
Stable liquid formulations of botulinum toxin
DK1323222T3
(en )
2007-04-02
The island and method of operating the island
DK1294644T3
(en )
2010-11-08
Water Treatment Compositions
ATE322251T1
(en )
2006-04-15
NEUROTOXIN IMPLANT
DK1063990T3
(en )
2007-05-21
Use of Biochanine-Enriched Extract for the Treatment of Estrogen-Associated Disorders
PT1250321E
(en )
2006-09-29
COMPOSITION OF GLIBURIDA
DK1282616T3
(en )
2004-09-20
Hydroxyphenylpiperidin-4-ylidene methylbenzamide derivatives for the treatment of pain
DK1450606T3
(en )
2011-05-23
Synergistic compositions for the treatment of seed
DK1183269T3
(en )
2007-04-02
Attenuated microorganisms for the treatment of infection
NO20032122L
(en )
2003-07-01
Improved treatment
DE60117938D1
(en )
2006-05-11
Preloading of components
NO20026219L
(en )
2003-02-17
Compounds for the treatment of impaired fundic relaxation
NO20024777D0
(en )
2002-10-03
Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
NO20024776L
(en )
2002-12-03
Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
DK1268482T3
(en )
2003-12-22
Pyranoindoles for the treatment of glaucoma
DK1237566T3
(en )
2005-03-07
Intrinsic compositions containing botulinum toxin for the treatment of pain
DK1311260T3
(en )
2008-06-23
Lipase inhibitors for the treatment of dyspepsia
NO20030946D0
(en )
2003-02-28
Medical compositions
DK1282414T3
(en )
2005-04-04
Felbamate-derived compounds for the treatment of neuropathic pain
DK1286986T3
(en )
2005-05-09
Quinolinylpiperidin-4-ylidene methylbenzamide derivatives for the treatment of pain